Clinical Trial Update: A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S [Phase 1, Phase 2]

View source ↗

Summary

Safety and efficacy study of ChAd63/MVA METRAP combined with RTS,S in malaria has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• ChAd63 (chimpanzee adenovirus vector encoding malaria antigens ME-TRAP, CS, AMA1)
• MVA METRAP (Modified Vaccinia Ankara METRAP vector)
• RTS,S malaria vaccine (RTS,S malaria vaccine (RTS,S/AS01))

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Falciparum Malaria | Phase 1, Phase 2 | Status: COMPLETED